Qun Wang1, Sek Ying Chair2, Eliza Mi-Ling Wong2. 1. The Nethersole School of Nursing, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong. Electronic address: qunwang@cuhk.edu.hk. 2. The Nethersole School of Nursing, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong.
Abstract
BACKGROUND/ OBJECTIVES: Lifestyle modification is recommended as the primary intervention for metabolic syndrome (MetS). The study was to examine the effects of a lifestyle intervention program (LIP) on physical outcomes, depression, and quality of life (QoL) in Chinese adults with MetS. METHODS: A randomized control trial design was used. A three-month LIP guided by the Health Promotion Model was developed, including a lifestyle modification booklet, one session of discharge education, and six telephone follow-ups. Patients with MetS were recruited from the inpatient departments of a hospital and were randomized to receive either the LIP or usual care. The physical outcomes, depression (Depression subscale of Hospital Anxiety and Depression Scale), and QoL (Medical Outcome Study Short Form-12, SF-12) were measured at baseline, one-month (T1) and three-month (T2). The effects of the LIP were examined by the generalized estimating equation (GEE) model. RESULTS: The study recruited 173 participants, with 86 in the intervention group and 87 in the control. Continuous improvements were observed in all the study outcomes in the intervention group. The GEE model revealed significant improvements in body weight (T1: p=0.017, T2: p=0.007), body mass index (T1: p=0.015, T2: p=0.009), depression (T1: p=0.027, T2: p<0.001), and physical aspects of QoL at T2 (p=0.02). CONCLUSIONS: The current LIP was effective in losing body weight, improving depression and QoL of MetS populations in three-month observation. Considering its low-cost and convenience, the LIP could be applied in clinical practice to improve patient outcomes.
RCT Entities:
BACKGROUND/ OBJECTIVES: Lifestyle modification is recommended as the primary intervention for metabolic syndrome (MetS). The study was to examine the effects of a lifestyle intervention program (LIP) on physical outcomes, depression, and quality of life (QoL) in Chinese adults with MetS. METHODS: A randomized control trial design was used. A three-month LIP guided by the Health Promotion Model was developed, including a lifestyle modification booklet, one session of discharge education, and six telephone follow-ups. Patients with MetS were recruited from the inpatient departments of a hospital and were randomized to receive either the LIP or usual care. The physical outcomes, depression (Depression subscale of Hospital Anxiety and Depression Scale), and QoL (Medical Outcome Study Short Form-12, SF-12) were measured at baseline, one-month (T1) and three-month (T2). The effects of the LIP were examined by the generalized estimating equation (GEE) model. RESULTS: The study recruited 173 participants, with 86 in the intervention group and 87 in the control. Continuous improvements were observed in all the study outcomes in the intervention group. The GEE model revealed significant improvements in body weight (T1: p=0.017, T2: p=0.007), body mass index (T1: p=0.015, T2: p=0.009), depression (T1: p=0.027, T2: p<0.001), and physical aspects of QoL at T2 (p=0.02). CONCLUSIONS: The current LIP was effective in losing body weight, improving depression and QoL of MetS populations in three-month observation. Considering its low-cost and convenience, the LIP could be applied in clinical practice to improve patient outcomes.
Authors: Enrique Albert Pérez; Marina Poveda González; Rosa María Martínez-Espinosa; Mariola D Molina Vila; Manuel Reig García-Galbis Journal: Int J Environ Res Public Health Date: 2019-09-18 Impact factor: 3.390
Authors: Eliza Mi Ling Wong; Doris Y P Leung; Hon Lon Tam; Qun Wang; Kai Wang Yeung; Angela Y M Leung Journal: Clin Interv Aging Date: 2021-04-16 Impact factor: 4.458
Authors: D C Sá-Caputo; L L Paineiras-Domingos; Ricardo Oliveira; Mario F T Neves; Andrea Brandão; Pedro J Marin; Borja Sañudo; Trentham Furness; Redha Taiar; M Bernardo-Filho Journal: Dose Response Date: 2018-10-07 Impact factor: 2.658